Company: LNAI
Filing Date: 2025-07-14
Form Type: 8-K
Source: 0001731122-25-000971
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-07-14
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing
Rule or Standard; Transfer of Listing

On July 7, 2025, Renovaro Inc. (the “ Company”) received a written
notice (the “ Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying
the Company that it is no longer in compliance with Nasdaq Listing Rule 5620(a), which requires that listed companies hold an annual meeting
of shareholders no later than one year after the end of their fiscal year.

The Company did not hold its annual meeting of shareholders within twelve
months of the end of its fiscal year ended June 30, 2024, and therefore did not satisfy this requirement. Pursuant to Nasdaq Listing Rule
5810(c)(2)(G), the Company has 45 calendar days from the date of the Notice to submit a plan to regain compliance. If Nasdaq accepts the
Company’s plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the fiscal year end, or until December
29, 2025, to regain compliance.

The Company is working diligently to submit a plan of compliance within
the required timeframe and intends to hold its annual meeting of shareholders as soon as practicable to regain compliance with Nasdaq’s
continued listing standards.

This notice does not immediately affect the listing or trading of the Company’s
common stock on Nasdaq. However, if the Company fails to timely submit a compliance plan or if Nasdaq does not accept the Company’s
plan, the Company’s common stock may be subject to delisting.

The Company intends to monitor its compliance with the applicable Nasdaq
Listing Rules and will take all necessary steps to maintain its Nasdaq listing.

Forward - Looking Statements